CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 60 filers reported holding CASI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $31,000 | -68.4% | 38,112 | -68.9% | 0.00% | -70.0% |
Q4 2021 | $98,000 | -32.9% | 122,453 | 0.0% | 0.01% | -37.5% |
Q3 2021 | $146,000 | -23.2% | 122,453 | 0.0% | 0.02% | -23.8% |
Q2 2021 | $190,000 | -44.9% | 122,453 | -14.8% | 0.02% | -51.2% |
Q1 2021 | $345,000 | – | 143,677 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields Capital Management, LLC | 2,188,547 | $1,751,000 | 0.22% |
Wellington Shields & Co., LLC | 1,141,190 | $913,000 | 0.18% |
Ikarian Capital, LLC | 1,223,067 | $978,000 | 0.15% |
Ground Swell Capital, LLC | 18,638 | $15,000 | 0.09% |
Anson Funds Management LP | 267,507 | $214,000 | 0.02% |
Sterneck Capital Management, LLC | 40,000 | $32,000 | 0.02% |
FEDERATED HERMES, INC. | 10,150,000 | $8,120,000 | 0.02% |
Roundview Capital LLC | 122,453 | $98,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,677,146 | $1,342,000 | 0.01% |
RBF Capital, LLC | 159,367 | $127,000 | 0.01% |